# Lisata Therapeutics, Inc.: Form 8-K, filed Aug 19, 2022

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2022-08-19
- Accepted by EDGAR: Aug 19, 2022, 12:33 ET
- Period: 2022-08-18
- Accession: 0000320017-22-000071
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001722000071/clbs-20220818.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001722000071/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001722000071/clbs-20220818.htm

Filed Aug 19, 2022.
Source: SEC EDGAR, the filing index for accession 0000320017-22-000071. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
